口腔科

订阅

MedSci主页 / 所有栏目 / 口腔科

J Endod：使用MTA或氢氧化钙实施去龋露髓的直接盖髓术疗效评估：1年随访调查

2019-06-06 lishiting MedSci原创

MTA直接盖髓疗效
关注

这篇临床随机对照试验的目的是为了比较龋源性露髓牙齿及可复性牙髓炎使用MTA或氢氧化钙(CH)实施直接盖髓术(DPC)的成功率及术后疼痛。

这篇临床随机对照试验的目的是为了比较龋源性露髓牙齿及可复性牙髓炎使用MTA或氢氧化钙(CH)实施直接盖髓术(DPC)的成功率及术后疼痛。研究将64颗去龋后的恒牙随机分为2组：CH和MTA (n = 32 in each group)。使用标准治疗程序覆盖暴露牙髓。一级疗效为术后12个月随访的成功率，二级疗效为术后7天的疼痛情况。术后3， 6和12个月临床和放射线影像评估患牙。采用可视化模拟量表每隔24小时记录术后疼痛情况，直至术后7天。结果显示，12个月后随访共分析检查了56颗牙齿，29颗施以CH和27颗施以ProRoot MTA (Dentsply Tulsa Dental， Tulsa， OK)。CH的成功率为69%和ProRoot MTA的成功率为93% (P < .05)。kappa值的评判一致性为0.773。尽管2组在术后6小时发生明显疼痛，但2组间的疼痛发生率无显著性差异(P > .05)。术后18小时，MTA组的疼痛评分(6.3 ± 9.5)明显低于CH组(18.5 ± 20.8)。结论：龋源性及可复性牙髓炎牙齿可以通过DPC获得治愈。基于治疗成功率和疼痛程度

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1661424, encodeId=317b1661424a6, content=<a href='/topic/show?id=6f1c98924de' target=_blank style='color:#2F92EE;'>#露髓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98924, encryptionId=6f1c98924de, topicName=露髓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b3b25278914, createdName=ms3117646317107274, createdTime=Fri Aug 30 02:47:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915703, encodeId=d6371915e032d, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sun Nov 17 23:47:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368055, encodeId=2cb3136805502, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569928, encodeId=a4d01569928cc, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032177, encodeId=1d6610321e7cb, content=谢谢梅斯提供这么好的信息，学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Thu Jun 06 11:47:00 CST 2019, time=2019-06-06, status=1, ipAttribution=)]
    2019-08-30 ms3117646317107274

    #露髓#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1661424, encodeId=317b1661424a6, content=<a href='/topic/show?id=6f1c98924de' target=_blank style='color:#2F92EE;'>#露髓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98924, encryptionId=6f1c98924de, topicName=露髓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b3b25278914, createdName=ms3117646317107274, createdTime=Fri Aug 30 02:47:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915703, encodeId=d6371915e032d, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sun Nov 17 23:47:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368055, encodeId=2cb3136805502, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569928, encodeId=a4d01569928cc, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032177, encodeId=1d6610321e7cb, content=谢谢梅斯提供这么好的信息，学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Thu Jun 06 11:47:00 CST 2019, time=2019-06-06, status=1, ipAttribution=)]
    2019-11-17 zxxiang

    #疗效评估#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1661424, encodeId=317b1661424a6, content=<a href='/topic/show?id=6f1c98924de' target=_blank style='color:#2F92EE;'>#露髓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98924, encryptionId=6f1c98924de, topicName=露髓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b3b25278914, createdName=ms3117646317107274, createdTime=Fri Aug 30 02:47:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915703, encodeId=d6371915e032d, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sun Nov 17 23:47:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368055, encodeId=2cb3136805502, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569928, encodeId=a4d01569928cc, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032177, encodeId=1d6610321e7cb, content=谢谢梅斯提供这么好的信息，学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Thu Jun 06 11:47:00 CST 2019, time=2019-06-06, status=1, ipAttribution=)]
    2019-06-07 liuxiaona

    #MTA#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1661424, encodeId=317b1661424a6, content=<a href='/topic/show?id=6f1c98924de' target=_blank style='color:#2F92EE;'>#露髓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98924, encryptionId=6f1c98924de, topicName=露髓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b3b25278914, createdName=ms3117646317107274, createdTime=Fri Aug 30 02:47:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915703, encodeId=d6371915e032d, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sun Nov 17 23:47:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368055, encodeId=2cb3136805502, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569928, encodeId=a4d01569928cc, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032177, encodeId=1d6610321e7cb, content=谢谢梅斯提供这么好的信息，学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Thu Jun 06 11:47:00 CST 2019, time=2019-06-06, status=1, ipAttribution=)]
    2019-06-07 tongyongming

    #氢氧化钙#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1661424, encodeId=317b1661424a6, content=<a href='/topic/show?id=6f1c98924de' target=_blank style='color:#2F92EE;'>#露髓#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98924, encryptionId=6f1c98924de, topicName=露髓)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b3b25278914, createdName=ms3117646317107274, createdTime=Fri Aug 30 02:47:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1915703, encodeId=d6371915e032d, content=<a href='/topic/show?id=2b40e04130e' target=_blank style='color:#2F92EE;'>#疗效评估#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70413, encryptionId=2b40e04130e, topicName=疗效评估)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Sun Nov 17 23:47:00 CST 2019, time=2019-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1368055, encodeId=2cb3136805502, content=<a href='/topic/show?id=de4912308e7' target=_blank style='color:#2F92EE;'>#MTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12308, encryptionId=de4912308e7, topicName=MTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569928, encodeId=a4d01569928cc, content=<a href='/topic/show?id=e14a6395908' target=_blank style='color:#2F92EE;'>#氢氧化钙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63959, encryptionId=e14a6395908, topicName=氢氧化钙)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8f315601930, createdName=tongyongming, createdTime=Fri Jun 07 23:47:00 CST 2019, time=2019-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032177, encodeId=1d6610321e7cb, content=谢谢梅斯提供这么好的信息，学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Thu Jun 06 11:47:00 CST 2019, time=2019-06-06, status=1, ipAttribution=)]
    2019-06-06 内科新手

    谢谢梅斯提供这么好的信息，学到很多

    0

相关资讯

J Endod：使用MTA即刻和延迟修复2种不同大小的根分叉穿孔

这篇组织学研究的目的是为了检测即刻和延迟MTA修复2种大小不同根分叉穿孔的牙周组织形态及形态测定变化。

J Dent Res：自限与常规龋坏去除的比较：一项临床随机试验

这项单盲临床随机对照试验的目的是为了比较化学机械Carisolv凝胶/手术显微镜的自限龋坏移除方案(自限)与旋转牙钻选择性移除硬质牙本质（对照）的方法对罹患深龋和有症状的可复性牙髓炎患者治疗效果的比较。随后，所有试验牙齿均通过MTA护髓，玻璃离子水门汀垫底复合树脂充填，所有诊疗均为单次完成。

J Endod：增强弹性蛋白样多肽类基质对MTA物理特性的作用研究

弹性蛋白样多肽(ELP)是一种遗传工程、蛋白类的多肽，它可以提供显著的好处，比如：优越的生物相容性、长效稳定性和费用效益。这篇研究的目的是为了评估ELP类基质对MTA生物相容性和物理特性的影响。

J Endod：Axl参与了MTA诱导巨噬细胞极化的过程

这篇研究的目的是为了检测MTA对巨噬细胞极化的功效以及Axl/nuclear factor kappa B (NF-κB)信号是否介导了MTA的作用。

J Endod：采用MTA或Biodentine对活髓牙的疗效观察：一项预期的临床随机试验

一直以来，MTA都被用来进行龋坏的发育成熟恒牙的盖髓治疗。而对于研发一种比MTA封闭效果更好，固化更快的替代材料从未停止过。Biodentine (Septodont, St Maur-des-Fossés, France)具备以上的特点，但是从未测试过它对成熟恒牙的长期效果。这篇研究的目的是为了评估和比较Biodentine和white MTA (Angelus, Londrina, Brazi

J Endod：ProRoot MTA或Biodentine能够促进人牙本质释放TGFβ-1

可能有多种因素会导致经过牙髓再生治疗牙齿的根管内钙化。生物活性材料，包括ProRoot MTA (MTA; Dentsply Tulsa Dental Specialties, Memphis, TN) and Biodentine (BD; Septodont, Saint-Maur-des-Fossés, France)被广泛应用于牙髓再生疗法中的最终冠方封闭。这篇研究的目的是为了评估应用MT